Vir Biotechnology, Inc.

VIR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$170,084$211,104$273,571$222,947
Short-Term Investments$336,429$394,915$528,091$682,401
Receivables$0$0$0$5,100
Inventory$0$0$0$0
Other Curr. Assets$39,171$129,687$130,545$132,010
Total Curr. Assets$545,684$735,706$932,207$1,042,458
Property Plant & Equip (Net)$121,758$125,648$120,240$122,863
Goodwill$16,937$16,937$16,937$16,937
Intangibles$7,924$7,998$8,072$8,098
Long-Term Investments$304,212$286,099$218,140$190,015
Tax Assets$0$0$0$0
Other NC Assets$22,938$20,144$12,131$18,420
Total NC Assets$473,769$456,826$375,520$356,333
Other Assets$0$0$0$22
Total Assets$1,019,453$1,192,532$1,307,727$1,398,813
Liabilities
Payables$6,847$12,234$3,725$5,081
Short-Term Debt$8,960$8,825$7,925$7,752
Tax Payable$0$0$0$0
Deferred Revenue$0$10,109$11,935$12,648
Other Curr. Liab.$59,415$73,836$113,701$94,181
Total Curr. Liab.$75,222$105,004$137,286$119,662
LT Debt$91,215$93,405$88,170$90,139
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$56,918$46,651$38,452$38,627
Total NC Liab.$148,133$140,056$126,622$128,766
Other Liabilities$0$0$0$0
Cap. Leases$100,175$102,230$96,095$97,891
Total Liabilities$223,355$245,060$263,908$248,428
Equity
Pref Stock$0$0$0$0
Common Stock$14$14$14$14
Retained Earnings-$1,154,848-$991,707-$880,749-$759,784
AOCI-$1,911-$2,221-$1,975-$1,717
Other Equity$1,952,843$1,941,386$1,926,529$1,911,872
Total Equity$796,098$947,472$1,043,819$1,150,385
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,019,453$1,192,532$1,307,727$1,398,813
Net Debt-$69,909-$108,874-$177,476-$125,056